메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한생물치료정신의학회 생물치료정신의학 생물치료정신의학 제10권 제1호
발행연도
2004.6
수록면
36 - 44 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Objective : This study was carried out to observe the change of body weight, glucose, and lipid metabolism during the atypical antipsychotics treatment.
Methods : Forty nine schizophrenic or schizoaffective patients were recruited and the patients with history of eating disorder were excluded. Body weight was checked with 4-week interval from baseline to the 48th week. Blood chemistry was checked twice at baseline and the 48th week for HbA1c, cholesterol, LDL, HDL, and triglyceride. The subjects were treated with risperidone(n=25) or olanzapine(n=24). The observations were done under natural course of the treatment without any limitation of dosage or combination of other drugs.
Results : After forty eight weeks of the treatment, subjects showed significant increase of body weight and BMI. They also had significant increase of HbA1c, cholesterol, LDL, and TG levels, but level of HDL decreased. The percent weight gain had negative correlation with initial BMI in both risperidone and olanzapine groups.
Conclusion : This results suggest that during the natural course of the atypical antipsychotics treatment, patients may have weight gain and abnormal lipid metabolism or glucose metabolism, and increased the risk of DM, or cardiovascular disease.

목차

영어 초록
서론
연구방법
결과
고찰
참고문헌

참고문헌 (36)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2009-513-017219437